Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Webmd Health Corp Q1, FY 2013 Guidance Above Analysts' Estimates


Thursday, 21 Feb 2013 04:00pm EST 

Webmd Health Corp announced that for fiscal 2013, it expects revenue to be approximately $430 million to $455 million, adjusted EBITDA to be approximately $60 million to $80 million and net loss from continuing operations to be approximately $(22) million to $(7) million, or $(0.45) to $(0.13) per diluted share. For first quarter of 2013, it expects revenue to be in excess of $105 million, adjusted EBITDA to be in excess of 13% of revenue, net loss from continuing operations to be approximately 6% of revenue. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $422 million, EBITDA of $55 million and EPS of $(0.44) for fiscal 2013; revenue of $94 million, EBITDA of $5 million and EPS of $(0.22) for first quarter of 2013. 

Company Quote

39.91
0.46 +1.17%
19 Dec 2014